Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BCG vaccination induces enhanced frequencies of dendritic cells and altered plasma levels of type I and type III interferons in elderly individuals.
Kumar NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, Nancy A, Jeyadeepa B, Selvaraj N, Ashokan D, Renji RM, Venkataramani V, Tripathy S, Babu S. Kumar NP, et al. Among authors: padmapriyadarsini c. Int J Infect Dis. 2021 Sep;110:98-104. doi: 10.1016/j.ijid.2021.07.041. Epub 2021 Jul 22. Int J Infect Dis. 2021. PMID: 34302964 Free PMC article.
A dose-finding study to guide use of verapamil as an adjunctive therapy in tuberculosis.
Padmapriyadarsini C, Szumowski JD, Akbar N, Shanmugasundaram P, Jain A, Bathragiri M, Pattnaik M, Turuk J, Karunaianantham R, Balakrishnan S, Pati S, Agibothu Kupparam HK, Rathore MK, Raja J, Naidu KR, Horn J, Whitworth L, Sewell R, Ramakrishnan L, Swaminathan S, Edelstein PH. Padmapriyadarsini C, et al. medRxiv [Preprint]. 2023 Aug 5:2023.07.28.23293316. doi: 10.1101/2023.07.28.23293316. medRxiv. 2023. Update in: Clin Pharmacol Ther. 2024 Feb;115(2):324-332. doi: 10.1002/cpt.3108. PMID: 37577511 Free PMC article. Updated. Preprint.
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.
Padmapriyadarsini C, Szumowski JD, Akbar N, Shanmugasundaram P, Jain A, Bathragiri M, Pattnaik M, Turuk J, Karunaianantham R, Balakrishnan S, Pati S, Kumar AKH, Rathore MK, Raja J, Naidu KR, Horn J, Whitworth L, Sewell R, Ramakrishnan L, Swaminathan S, Edelstein PH. Padmapriyadarsini C, et al. Clin Pharmacol Ther. 2024 Feb;115(2):324-332. doi: 10.1002/cpt.3108. Epub 2023 Dec 11. Clin Pharmacol Ther. 2024. PMID: 37983978 Free PMC article. Clinical Trial.
Characterising cause of death among people treated for drug-susceptible TB in India.
Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar SVBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Golub JE. Cox SR, et al. Among authors: padmapriyadarsini c. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):78-80. doi: 10.5588/ijtld.22.0454. Int J Tuberc Lung Dis. 2023. PMID: 36853129 Free PMC article. No abstract available.
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R. Swaminathan S, et al. Among authors: padmapriyadarsini c. Clin Infect Dis. 2011 Oct;53(7):716-24. doi: 10.1093/cid/cir447. Clin Infect Dis. 2011. PMID: 21890776 Clinical Trial.
Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.
Padmapriyadarsini C, Bhavani PK, Tang A, Kumar H, Ponnuraja C, Narendran G, Hannah E, Ramesh C, Chandrasekar C, Wanke C, Swaminathan S. Padmapriyadarsini C, et al. Int J Infect Dis. 2013 Dec;17(12):e1154-9. doi: 10.1016/j.ijid.2013.08.006. Epub 2013 Sep 13. Int J Infect Dis. 2013. PMID: 24120216 Free PMC article. Clinical Trial.
Tuberculosis among the homeless in Chennai city, South India.
Dolla C, Padmapriyadarsini C, Pradeep Menon A, Muniyandi M, Adinarayanan S, Sekar G, Kavitha D, Tripathy SP, Swaminathan S. Dolla C, et al. Among authors: padmapriyadarsini c. Trans R Soc Trop Med Hyg. 2017 Oct 1;111(10):479-481. doi: 10.1093/trstmh/trx081. Trans R Soc Trop Med Hyg. 2017. PMID: 29346636
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Padmapriyadarsini C, Bhavani PK, Natrajan M, Ponnuraja C, Kumar H, Gomathy SN, Guleria R, Jawahar SM, Singh M, Balganesh T, Swaminathan S. Padmapriyadarsini C, et al. BMJ Open. 2019 Mar 1;9(3):e024363. doi: 10.1136/bmjopen-2018-024363. BMJ Open. 2019. PMID: 30826761 Free PMC article.
121 results